UBS Group’s T. Rowe Price Capital Appreciation Equity ETF TCAF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$39.1M Sell
950,353
-95,828
-9% -$3.79M 0.01% 1996
2026
Q1
$37.2M Buy
1,046,181
+35,338
+3% +$1.32M 0.01% 1934
2025
Q4
$38.6M Buy
1,010,843
+267,154
+36% +$10.2M 0.01% 1900
2025
Q3
$28M Buy
743,689
+63,852
+9% +$2.33M ﹤0.01% 2201
2025
Q2
$24M Buy
679,837
+187,573
+38% +$6.15M ﹤0.01% 2178
2025
Q1
$15.9M Buy
492,264
+110,523
+29% +$3.71M ﹤0.01% 2576
2024
Q4
$12.7M Buy
381,741
+28,593
+8% +$964K ﹤0.01% 2802
2024
Q3
$11.7M Buy
353,148
+24,768
+8% +$793K ﹤0.01% 2225
2024
Q2
$10.3M Buy
328,380
+89,676
+38% +$2.72M ﹤0.01% 2190
2024
Q1
$7.22M Buy
238,704
+160,302
+204% +$4.62M ﹤0.01% 2577
2023
Q4
$2.17M Buy
+78,402
New +$2.03M ﹤0.01% 3730

Other funds holding TCAF

UBS Group's TCAF Position: Q2 2026 in Review

UBS Group reduced its T. Rowe Price Capital Appreciation Equity ETF (TCAF) stake by 9.2% in Q2 2026, selling an estimated $3.79M and leaving 950,353 shares worth $39.1M. The position accounts for 0.01% of the portfolio, ranked #1996.

UBS Group first reported a position in TCAF in Q4 2023 and has held it in 11 quarters since. 359 funds tracked by Wall St. Rank hold TCAF as of Q2 2026.

  • UBS Group held 950,353 shares of T. Rowe Price Capital Appreciation Equity ETF worth $39.1M as of Q2 2026.
  • UBS Group sold 95,828 T. Rowe Price Capital Appreciation Equity ETF shares in Q2 2026, an estimated $3.79M.
  • T. Rowe Price Capital Appreciation Equity ETF made up 0.01% of UBS Group's portfolio in Q2 2026, its #1996 holding.
  • UBS Group first reported a position in T. Rowe Price Capital Appreciation Equity ETF in Q4 2023 and has held it in 11 quarters since.
  • 359 funds tracked by Wall St. Rank held T. Rowe Price Capital Appreciation Equity ETF as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.